These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22093966)

  • 1. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
    Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
    BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
    Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
    BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
    Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
    BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer.
    Braeckman J; Autier P; Garbar C; Marichal MP; Soviany C; Nir R; Nir D; Michielsen D; Bleiberg H; Egevad L; Emberton M
    BJU Int; 2008 Feb; 101(3):293-8. PubMed ID: 17922870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers.
    Braeckman J; Autier P; Soviany C; Nir R; Nir D; Michielsen D; Treurnicht K; Jarmulowicz M; Bleiberg H; Govindaraju S; Emberton M
    BJU Int; 2008 Dec; 102(11):1560-5. PubMed ID: 18710457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
    Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
    Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
    Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
    BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience.
    Sivaraman A; Sanchez-Salas R; Barret E; Macek P; Validire P; Galiano M; Rozet F; Cathelineau X
    World J Urol; 2015 Oct; 33(10):1475-9. PubMed ID: 25501797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
    Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D
    Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate 3D ultrasound-guided imaging device (HistoScanning) performance detecting clinically significant prostate cancer.
    Vezelis Alvydas A; Platkevicius G; Kincius KM; Naruseviciute I; Ulys A; Jankevicius F
    J BUON; 2020; 25(1):460-463. PubMed ID: 32277669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer.
    Pavlovich CP; Cornish TC; Mullins JK; Fradin J; Mettee LZ; Connor JT; Reese AC; Askin FB; Luck R; Epstein JI; Burke HB
    Urol Oncol; 2014 Jan; 32(1):34.e27-32. PubMed ID: 23558161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.
    Simmons LAM; Kanthabalan A; Arya M; Briggs T; Charman SC; Freeman A; Gelister J; Jameson C; McCartan N; Moore CM; van der Muelen J; Emberton M; Ahmed HU
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):261-267. PubMed ID: 30279583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
    Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
    Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study.
    Macek P; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Ahallal Y; Gaya JM; Durant M; Mascle L; Giedelman C; Lunelli L; Validire P; Nesvadba M; Cathelineau X
    J Endourol; 2014 Mar; 28(3):371-6. PubMed ID: 24032370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time elastography for detecting prostate cancer: preliminary experience.
    Pallwein L; Mitterberger M; Struve P; Pinggera G; Horninger W; Bartsch G; Aigner F; Lorenz A; Pedross F; Frauscher F
    BJU Int; 2007 Jul; 100(1):42-6. PubMed ID: 17552952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.